200
Participants
Start Date
March 31, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2014
NL003
Day 0: 8mg of NL003 (32 injections of 0.5ml of NL003) Day 14: 8mg of NL003 (32 injections of 0.5ml of NL003) Day 28: 8mg of NL003 (32 injections of 0.5ml of NL003)
NL003
Day 0: 6mg of NL003 (24 injections of 0.5ml of NL003) and 4ml normal saline(8 injections) Day 14: 6mg of NL003 (24 injections of 0.5ml of NL003) and 4ml normal saline(8 injections) Day 28: 6mg of NL003 (24 injections of 0.5ml of NL003) and 4ml normal saline(8 injections)
NL003
Day 0: 4mg of NL003 (16 injections of 0.5ml of NL003) and 8ml normal saline(16 injections) Day 14: 4mg of NL003 (16 injections of 0.5ml of NL003) and 8ml normal saline(16 injections) Day 28: 4mg of NL003 (16 injections of 0.5ml of NL003) and 8ml normal saline(16 injections)
Normal Saline
Day 0: 16ml of Normal Saline (32 injections ) Day 14: 16ml of Normal Saline (32 injections ) Day 28: 16ml of Normal Saline (32 injections )
Peking Union Medical College Hospital, Beijing
Beijing Shijitan Hospital, Beijing
Xuanwu Hospital Capital Medical University, Beijing
The General Hospital of the People's Liberation Army, Beijing
First Hospital of Jilin University, Changchun
Nanjing Drum Tower Hospital, Nanjing
Wuhan Union Hospital, Wuhan
The Second Xiangya Hospital of Central South University, Changsha
The Second Hospital of Dalian Medical University, Dalian
Beijing Northland Biotech. Co., Ltd.
INDUSTRY